Abstract
Ghrelin is mainly expressed in the stomach, followed by lower parts of the gastrointestinal tract, Ghrelin secretion is mainly influenced by changes in energy balance and glucose homeostasis, followed by alterations of endocrine axes. Ghrelin therefore seems to be an interface between energy homeostasis, glucose metabolism and physiological processes regulated by the classical endocrine axes that e.g., control growth. Ghrelin most likely defends fat mass to ensure survival and to provide the calories that are needed for growth hormone to act on growth and repair. The possibility of using a ghrelin antagonist for the treatment of obesity initiated a hunt for such a valuable agent. It will not be long before antagonists are disclosed and tested for the treatment of obesity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bowers CY. Growth hormone-releasing peptide (GHRP). Cell Mol Life Sci. 1998; 54:1316–29.
Momany FA, Bowers CY, Reynolds GA, Chang D, Hong A, Newlander K. Design, synthesis, and biological activity of peptides which release growth hormone in vitro. Endocrinology. 1981; 108:31–9.
Smith RG, Van der Ploeg LH, Howard AD, et al. Peptidomimetic regulation of growth hormone secretion. Endocr Rev. 1997; 18:621–45.
Patchett AA, Nargund RP, Tata JR, et al. Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue. Proc Natl Acad Sci USA. 1995; 92:7001–5.
Chapman IM, Bach MA, Van Cauter E, et al. Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects. J Clin Endocrinol Metab. 1996; 81:4249–57.
Thorner MO. Theodore R. Woodward Award. Age-related decline in growth hormone secretion: clinical significance and potential reversibility. Trans Am Clin Climatol Assoc. 1996; 108:99–105; discussion 105–8.
Chapman IM, Pescovitz OH, Murphy G, et al. Oral administration of growth hormone (GH) releasing peptide-mimetic MK-677 stimulates the GH/insulin-like growth factor-I axis in selected GH-deficient adults. J Clin Endocrinol Metab. 1997; 82:3455–63.
Svensson J, Ohlsson C, Jansson JO, et al. Treatment with the oral growth hormone secretagogue MK-677 increases markers of bone formation and bone resorption in obese young males. J Bone Miner Res. 1998; 13:1158–66.
Schleim KD, Jacks T, Cunningham P, et al. Increases in circulating insulin-like growth factor I levels by the oral growth hormone secretagogue MK-0677 in the beagle are dependent upon pituitary mediation. Endocrinology. 1999; 140:1552–8.
Murphy MG, Weiss S, McClung M, et al. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. J Clin Endocrinol Metab. 2001; 86:1116–25.
Gertz BJ, Barrett JS, Eisenhandler R, et al. Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6. J Clin Endocrinol Metab. 1993; 77:1393–7.
Bluet-Pajot MT, Tolle V, Zizzari P, et al. Growth hormone secretagogues and hypothalamic networks. Endocrine. 2001; 14:1–8.
Gnanapavan S, Kola B, Bustin SA, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab. 2002; 87:2988–91.
Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999; 402:656–60.
Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000; 141:4255–61.
Korbonits M, Kojima M, Kangawa K, Grossman AB. Presence of ghrelin in normal and adenomatous human pituitary. Endocrine. 2001; 14:101–4.
Muccioli G, Tschop M, Papotti M, Deghenghi R, Heiman M, Ghigo E. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol. 2002; 440:235–54.
Cassoni P, Papotti M, Ghe C, et al. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab. 2001; 86:1738–45.
Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000; 407:908–13.
Wren AM, Small CJ, Ward HL, et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology. 2000; 141:4325–8.
Broglio F, Arvat E, Benso A, et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab. 2001; 86:5083–6.
Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001; 86:5992–5.
Tena-Sempere M, Barreiro ML, Gonzalez LC, et al. Novel expression and functional role of ghrelin in rat testis. Endocrinology. 2002; 143:717–25.
Egido EM, Rodriguez-Gallardo J, Silvestre RA, Marco J. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur J Endocrinol. 2002; 146:241–4.
Zhang W, Chen M, Chen X, Segura BJ, Mulholland MW. Inhibition of pancreatic protein secretion by ghrelin in the rat. J Physiol. 2001; 537:231–6.
Jeffery PL, Herington AC, Chopin LK. Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines. J Endocrinol. 2002; 172:R7–11.
Casanueva FF, Dieguez C. Growth Hormone Secretagogues: Physiological Role and Clinical Utility. Trends Endocrinol Metab. 1999; 10:30–8.
Bodart V, Febbraio M, Demers A, et al. CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ Res. 2002; 90:844–9.
Okumura H, Nagaya N, Enomoto M, Nakagawa E, Oya H, Kangawa K. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J Cardiovasc Pharmacol. 2002; 39:779–83.
Yoshihara F, Kojima M, Hosoda H, Nakazato M, Kangawa K. Ghrelin: a novel peptide for growth hormone release and feeding regulation. Curr Opin Clin Nutr Metab Care. 2002; 5:391–5.
Hattori N, Saito T, Yagyu T, Jiang BH, Kitagawa K, Inagaki C. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J Clin Endocrinol Metab. 2001; 86:4284–91.
Dornonville de la Cour, Bjorkqvist M, Sandvik AK, et al. A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regul Pept. 2001; 99:141–50.
Mori K, Yoshimoto A, Takaya K, et al. Kidney produces a novel acylated peptide, ghrelin. FEBS Lett. 2000; 486:213–6.
Gualillo O, Caminos J, Blanco M, et al. Ghrelin, a novel placental-derived hormone. Endocrinology. 2001; 142:788–94.
Volante M, Papotti M, Gugliotta P, Migheli A, Bussolati G. Extensive DNA fragmentation in oxyphilic cell lesions of the thyroid. J Histochem Cytochem. 2001; 49:1003–11.
Tanaka M, Hayashida Y, Nakao N, Nakai N, Nakashima K. Testis-specific and developmentally induced expression of a ghrelin gene-derived transcript that encodes a novel polypeptide in the mouse. Biochim Biophys Acta. 2001; 1522:62–5.
Chapman IM, Hartman ML, Pezzoli SS, Thorner MO. Enhancement of pulsatile growth hormone secretion by continuous infusion of a growth hormone-releasing peptide mimetic, L-692,429, in older adults-a clinical research center study. J Clin Endocrinol Metab. 1996; 81:2874–80.
Volante M, Fulcheri E, AllIa E, Cerrato M, Pucci A, Papotti M. Ghrelin expression in fetal, infant, and adult human lung, J Histochem Cytochem. 2002; 50:1013–21.
Saad MF, Bernaba B, Hwu CM, et al. Insulin regulates plasma ghrelin concentration. J Clin Endocrinol Metab. 2002; 87:3997–4000.
Mohlig M, Spranger J, Otto B, Ristow M, Tschop M, Pfeiffer AF. Euglycemic hyperinsulinemia, but not lipid infusion, decreases circulating ghrelin levels in humans. J Endocrinol Invest 2002; 25:RC36–8.
Nakagawa E, Nagaya N, Okumura H, et al. Hyperglycaemia suppresses the secretion of ghrelin, a novel growth-hormone-releasing peptide: responses to the intravenous and oral administration of glucose. Clin Sci (Lond). 2002; 103:325–8.
Tschop M, Flora DB, Mayer JP, Heiman ML. Hypophysectomy prevents ghrelin-induced adiposity and increases gastric ghrelin secretion in rats. Obes Res. 2002; 10:991–9.
Cappiello V, Ronchi C, Morpurgo PS, et al. Circulating ghrelin levels in basal conditions and during glucose tolerance test in acromegalic patients. Eur J Endocrinol. 2002; 147:189–94.
van der Toorn FM, Janssen JA, De Herder WW, Broglio F, Ghigo E, Van Der Lely AJ. Central ghrelin production does not substantially contribute to systemic ghrelin concentrations; a study in two subjects with active acromegaly. Eur J Endocrinol. 2002; 147:195–9.
Muller AF, Lamberts SW, Janssen JA, et al. Ghrelin drives GH secretion during fasting in man. Eur J Endocrinol. 2002; 146:203–7.
Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev. 1999; 20:68–100.
Mustonen AM, Nieminen P, Hyvarinen H. Preliminary evidence that pharmacologic melatonin treatment decreases rat ghrelin levels. Endocrine. 2001; 16:43–6.
Masuda Y, Tanaka T, Inomata N, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun. 2000; 276:905–8.
Tschop M, Wawarta R, Riepl RL, et al. Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest. 2001; 24:RC19–21.
Asakawa A, Inui A, Kaga T, et al. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin. Gastroenterology. 2001; 120:337–45.
Toshinai K, Mondal MS, Nakazato M, et al. Upregulation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem Biophys Res Commun. 2001; 281:1220–5.
Hayashida T, Murakami K, Mogi K, et al. Ghrelin in domestic animals: distribution in stomach and its possible role. Domest Anim Endocrinol. 2001; 21:17–24.
Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002; 346:1623–30.
Ariyasu H, Takaya K, Hosoda H, et al. Delayed Short-Term Secretory Regulation of Gherlin in Obese Animals: Evidenced by a Specific RIA for the Active Form of Ghrelin. Endocrinology. 2002; 143:3341–50.
Adeghate E, Ponery AS. Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats. J Neuroendocrinol. 2002; 14:555–60.
Caixas A, Bashore C, Nash W, Pi-Sunyer F, Laferrere B. Insulin, unlike food intake, does not suppress ghrelin in human subjects. J Clin Endocrinol Metab. 2002; 87:1902–6.
Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001; 50:1714–9.
Arvat E, Di Vito L, Broglio F, et al. Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest. 2000; 23:493–5.
Arvat E, Maccario M, Di Vito L, et al. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab. 2001; 86:1169–74.
Guan XM, Yu H, Palyha OC, et al. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res. 1997; 48:23–9.
Shuto Y, Shibasaki T, Wada K, et al. Generation of polyclonal antiserum against the growth hormone secretagogue receptor (GHS-R): evidence that the GHS-R exists in the hypothalamus, pituitary and stomach of rats. Life Sci. 2001; 68:991–6.
Papotti M, Cassoni P, Volante M, Deghenghi R, Muccioli G, Ghigo E. Ghrelinproducing endocrine tumors of the stomach and intestine. J Clin Endocrinol Metab. 2001; 86:5052–9.
Hosoda H, Kojima M, Matsuo H, Kangawa K. Purification and characterization of rat des-Gln14-Ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor. J Biol Chem. 2000; 275:21995–22000.
Sakata I, Nakamura K, Yamazaki M, et al. Ghrelin-producing cells exist as two types of cells, closed-and opened-type cells, in the rat gastrointestinal tract. Peptides. 2002; 23:531–6.
Trudel L, Tomasetto C, Rio MC, et al. Ghrelin/motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat. Am J Physiol Gastrointest Liver Physiol. 2002; 282:G948–52.
Murakami N, Hayashida T, Kuroiwa T, et al. Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats. J Endocrinol. 2002; 174:283–8.
Date Y, Nakazato M, Murakami N, Kojima M, Kangawa K, Matsukura S. Ghrelin acts in the central nervous system to stimulate gastric acid secretion. Biochem Biophys Res Commun. 2001; 280:904–7.
Date Y, Nakazato M, Hashiguchi S, et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes. 2002; 51:124–9.
Volante M, AllIa E, Gugliotta P, et al. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J Clin Endocrinol Metab. 2002; 87:1300–8.
Lee HM, Wang G, Englander EW, Kojima M, Greeley GH Jr. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology. 2002; 143:185–90.
Ariyasu H, Takaya K, Tagami T, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab. 2001; 86:4753–8.
Tolle V, Bassant MH, Zizzari P, et al. Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats. Endocrinology. 2002; 143:1353–61.
Pagotto U, Gambineri A, Vincennati V, Heiman ML, Tschop M, Pasquali R. Plasma ghrelin, obesity and the polycystic ovary syndrome: Correlation with insulin resistance and androgen levels. J Clin Endocrinol Metab. 2002; 87:5625–9.
Svensson J, Lonn L, Jansson JO, et al. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. J Clin Endocrinol Metab. 1998; 83:362–9.
Muller AF, Janssen JA, Hofland LJ, et al. Blockade of the growth hormone (GH) receptor unmasks rapid GH-releasing peptide-6-mediated tissue-specific insulin resistance. J Clin Endocrinol Metab. 2001; 86:590–3.
Murata M, Okimura Y, Iida K, et al. Ghrelin modulates the downstream molecules of insulin signaling in hepatoma cells. J Biol Chem. 2002; 277:5667–74.
Cryer PE, Polonsky K. Glucose homeostasis and hypoglycemia. In: Wilson JD, ed. Williams Textbook of Endocrinology. Philadelphia: W.B. Saunders Company. 1998: 939–72.
Lucidi P, Murdolo G, Di Loreto C, et al. Ghrelin is not necessary for adequate hormonal counterregulation of insulin-induced hypoglycemia. Diabetes. 2002; 51:2911–4.
Cummings DE, Clement K, Purnell JQ, et al. Elevated plasma ghrelin levels in Prader Willi syndrome. Nat Med. 2002; 8:643–4.
Shepherd BS, Eckert SM, Parhar IS, et al. The hexapeptide KP-102 (D-ala-D-beta-Nalala-trp-D-phe-lys-NH(2)) stimulates growth hormone release in a cichlid fish (Ooreochromis mossambicus). J Endocrinol. 2000; 167:R7–10.
Furuse M, Tachibana T, Ohgushi A, Ando R, Yoshimatsu T, Denbow DM. Intracerebroventricular injection of ghrelin and growth hormone releasing factor inhibits food intake in neonatal chicks. Neurosci Lett. 2001; 301:123–6.
Kaiya H, Kojima M, Hosoda H, et al. Bullfrog ghrelin is modified by n-octanoic acid at its third threonine residue. J Biol Chem. 2001; 276:40441–8.
Nieminen P, Mustonen AM, Lindstrom-Seppa P, Asikainen J, Mussalo-Rauhamaa H, Kukkonen JV. Phytosterols act as endocrine and metabolic disruptors in the European polecat (Mustela putorius). Toxicol Appl Pharmacol. 2002; 178:22–8.
Nieminen P, Mustonen AM, Asikainen J, Hyvarinen H. Seasonal weight regulation of the raccoon dog (Nyctereutes procyonoides): interactions between melatonin, leptin, ghrelin, and growth hormone. J Biol Rhythms. 2002; 17:155–63.
Tomasetto C, Wendling C, Rio MC, Poitras P. Identification of cDNA encoding motilin related peptide/ghrelin precursor from dog fundus. Peptides. 2001; 22:2055–59.
Ahmed S, Harvey S. Ghrelin: a hypothalamic GH-releasing factor in domestic fowl (Gallus domesticus). J Endocrinol. 2002; 172:117–25.
Mustonen AM, Nieminen P, Hyvarinen H. Leptin, ghrelin, and energy metabolism of the spawning burbot (Lota lota, L.). J Exp Zool. 2002; 293:119–26.
Galas L, Chartrel N, Kojima M, Kangawa K, Vaudry H. Immunohistochemical localization and biochemical characterization of ghrelin in the brain and stomach of the frog Rana esculenta. J Comp Neurol. 2002; 450:34–44.
Mustonen AM, Nieminen P, Hyvarinen H. Melatonin and the Wintering Strategy of the Tundra Vole, Microtus oeconomus, Zoolog Sci. 2002; 19:683–7.
Sugino T, Hasegawa Y, Kikkawa Y, et al. A transient ghrelin surge occurs just before feeding in a scheduled meal-fed sheep. Biochem Biophys Res Commun. 2002; 295:255–60.
Riley LG, Hirano T, Grau EG. Rat Ghrelin Stimulates Growth Hormone and Prolactin Release in the Tilapia, Oreochromis mossambicus. Zoolog Sci. 2002; 19:797–800.
Heiman ML, Tschop M. Ghrelin provides the calories that growth hormone requires for growth and repair. Topic Endocrinol Suppl. 2001; 2:39–40.
Horvath TL, Diano S, Sotonyi P, Heiman M, Tschop M. Minireview: ghrelin and the regulation of energy balance—a hypothalamic perspective. Endocrinology. 2001; 142:4163–9.
Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001; 50:707–9.
Hansen TK, Dall R, Hosoda H, et al. Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol. 2002; 56:203–6.
Shiiya T, Nakazato M, Mizuta M, et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab. 2002; 87:240–4.
Otto B, Cuntz U, Fruehauf E, et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol. 2001; 145:669–73.
Wisse BE, Frayo RS, Schwartz MW, Cummings DE. Reversal of cancer anorexia by blockade of central melanocortin receptors in rats. Endocrinology. 2001; 142:3292–301.
Nagaya N, Uematsu M, Kojima M, et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation. 2001; 104:2034–8.
Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996; 334:292–5.
Jequier E. Pathways to obesity. Int J Obes Relat Metab Disord. 2002; 26(Suppl 2):S12–7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer Science + Business Media, Inc.
About this chapter
Cite this chapter
Gauna, C., van der Lely, A.J. (2004). Metabolic Actions of Ghrelin. In: Ghigo, E., Benso, A., Broglio, F. (eds) Ghrelin. Endocrine Updates, vol 23. Springer, Boston, MA. https://doi.org/10.1007/1-4020-7971-0_11
Download citation
DOI: https://doi.org/10.1007/1-4020-7971-0_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4020-7770-8
Online ISBN: 978-1-4020-7971-9
eBook Packages: Springer Book Archive